Pfizer is consulting about CSO taking over many products

[anonymous]

HQ is consulting options for all products making less than 300mil a year & giving to CSO or selling off for cash.
Both options would be a better ROI for most lower selling products.
Derm & Biosimilars high on review list as neither will make billions & the reps are highest paid in the industry.

 

[anonymous]

Makes 100% business sense financially & reality .

 

[anonymous]

Sad part is over the last ten years ive spent some time as both a CSO and a "highly paid" rep...My performance was above average in each role just made less than half in the CSO role. It is the wave of the future because there is an endless supply of laid off reps unfortunately willing to work for peanuts especially these days.